United States Real-World Evidence Solutions Market Future Outlook & Analysis 2025 | Major Players 2025 - IQVIA, ICON, PAREXEL

"Real-World Evidence Solutions Market is anticipated to grow at high CAGR during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/real-world-evidence-solutions-market?sp

United States: Recent Real-World Evidence Solutions Developments

✅ In September 2025, IQVIA launched a new RWE platform integrating AI-driven analytics for oncology studies in North Carolina.The platform accelerates clinical insights from real-world patient data.It supports precision medicine and faster regulatory submissions.

✅ In August 2025, Syneos Health invested $20 million to expand its RWE capabilities in Maryland.The investment enhances data collection, analytics, and patient outcomes monitoring for pharmaceutical clients.Operations are expected to scale by early 2026.

✅ In July 2025, Cognizant partnered with a major US health system to implement RWE solutions for cardiovascular therapies in California.The collaboration aims to optimize treatment protocols and improve patient care outcomes.It leverages electronic health records and claims data.

✅ In June 2025, Parexel introduced a cloud-based RWE platform supporting multi-therapeutic area studies in Massachusetts.The solution integrates real-world clinical, claims, and patient-reported data.It enhances post-market surveillance and regulatory reporting efficiency.

Japan: Recent Real-World Evidence Solutions Developments

✅ In September 2025, M3, Inc. launched an RWE platform for oncology and rare diseases in Tokyo.The platform aggregates electronic health records and claims data to generate actionable insights.It supports drug development and regulatory submissions.

✅ In August 2025, Fujitsu announced a collaboration with Japanese hospitals to expand RWE analytics for diabetes therapies in Osaka.The initiative focuses on real-world patient outcomes and treatment effectiveness.Pilot studies are ongoing in select medical centers.

✅ In July 2025, Takeda Pharmaceuticals implemented a nationwide RWE system for gastrointestinal disorders in Kyoto.The system collects longitudinal patient data to support clinical decision-making.It aligns with Japan's healthcare digitalization strategy.

✅ In June 2025, Sumitomo Dainippon Pharma completed the rollout of an AI-powered RWE analytics platform in Fukuoka.The solution enhances predictive modeling for treatment outcomes and market access insights.It is being integrated into ongoing post-marketing studies.

Real-World Evidence Solutions Market: Drivers

The real-world evidence (RWE) solutions market is experiencing rapid growth as pharmaceutical companies, healthcare providers, and payers increasingly rely on real-world data to inform clinical, regulatory, and commercial decisions. Rising adoption is driven by the need to understand treatment effectiveness, safety, and patient outcomes outside of controlled clinical trials. Additionally, growing emphasis on value-based care, personalized medicine, and healthcare cost optimization is fueling demand. Increasing availability of electronic health records, claims data, patient registries, and wearable health devices is expanding the data ecosystem. Regulatory agencies and payers are also encouraging the use of RWE to support drug approvals, reimbursement, and post-market surveillance, further driving market growth.

Technological advancements are significantly enhancing real-world evidence solutions. Innovations in data integration, analytics platforms, and AI-driven modeling enable robust insights from large and diverse datasets. Advanced predictive analytics, machine learning, and natural language processing allow extraction of meaningful information from structured and unstructured health data. Cloud-based platforms and secure data management solutions improve accessibility, scalability, and compliance with privacy regulations. Continuous improvements in visualization tools, dashboards, and reporting systems support actionable insights for clinicians, researchers, and policymakers. With ongoing innovation and growing reliance on real-world data, the RWE solutions market is poised for substantial growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/real-world-evidence-solutions-market?sp

Real-World Evidence Solutions Market: Major Players

IQVIA, ICON, PAREXEL, Pharmaceutical Product Development, and Optum, Cognizant, Oracle, SAS, Syneos Health, Clinigen Group, WuXi AppTech, Happy Life Tech

Segment Covered in the Real-World Evidence Solutions Market:

➥ By Component: Datasets, Services

➥ By Therapeutic Area: Oncology, Cardiology, Neurology, Immunology, Others

➥ By End-User: Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers, Other End Users

Research Process:

Both primary and secondary data sources have been used in the Real-World Evidence Solutions Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Real-World Evidence Solutions Market Research Industry:

➠ Who leads the Real-World Evidence Solutions industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Real-World Evidence Solutions market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Real-World Evidence Solutions market growth?
➠ What are the dominant sales and distribution strategies in the Real-World Evidence Solutions industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=real-world-evidence-solutions-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.